Leading drug makers Lupin and Sun Pharma have announced to recall different products in the US.
According to USFDA, Lupin will recall 11,688 bottles of Lisinopril tablets USP, 10 mg. Similarly, a US-based subsidiary of Mumbai-based Sun Pharma will recall 3,516 bottles of antiepileptic drug, Clonazepam orally disintegrating tablets.
Lisinopril tablets is used to treat high blood pressure. USFDA said Lupin is recalling the specific number of bottles due to presence of foreign tablets. Lisinopril tablets USP, (20 mg) were found in a 1,000 count bottle of Lisinopril Tablets USP (10 mg), it noted.
The tablets have been manufactured at Lupin’s Nagpur facility.
The USFDA has classified it as a Class-II recall, which is initiated in a “situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.
The USFDA listed the reason for the recall as “cross contamination with other products”.
Sun Pharmaceutical Industries, Inc initiated the nationwide recall of antiepileptic drug, Clonazepam on July 6. The USFDA has classified the action as a Class-III recall, which is initiated in a situation “in which use of or exposure to a violative product is not likely to cause adverse health consequences.”